Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Illness01:17

Classification of Illness

8.2K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.2K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

124
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
124
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

154
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
154
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

321
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
321
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

376
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
376
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

509
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
509

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Service Delivery Outcomes From Nursing in Genomics: A Scoping Review of the Literature (2012-2025).

International nursing review·2026
Same author

Frailty and Heart Failure: An Integrated Review of a Bidirectional Relationship.

ESC heart failure·2026
Same author

Bridging the implementation gap in cardiovascular prevention: a narrative review and call to action.

International journal of public health·2026
Same author

Physical Frailty, Self-Care Behaviors, and 6-Month Clinical Outcomes Among Adults With Heart Failure.

The Journal of cardiovascular nursing·2026
Same author

Obesity Definitions and Hospital Stay in Older Adults with Heart Failure: A Post Hoc Analysis of a Prospective Cohort.

Cardiac failure review·2026
Same author

Facilitators and Barriers to the Provision of End-of-Life Care Among Critical Care Nurses in Adult Intensive Care Units: An Integrative Review.

Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association·2026

Related Experiment Video

Updated: Nov 6, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.4K

Validating online approaches for rare disease research using latent class mixture modeling.

Andrew A Dwyer1,2, Ziwei Zeng3, Christopher S Lee4,5

  • 1Boston College Connell School of Nursing, Chestnut Hill, MA, USA. andrew.dwyer@bc.edu.

Orphanet Journal of Rare Diseases
|May 11, 2021
PubMed
Summary

Online recruitment for rare disease research, like congenital hypogonadotropic hypogonadism (CHH), is valid. Distinct patient subgroups were identified, refuting claims of homogenous samples and high needs in this congenital hypogonadotropic hypogonadism cohort.

Keywords:
Community based participatory researchDiagnostic odysseyHypogonadotropic hypogonadismKallmann syndromePatient organizationRare disease

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K

Related Experiment Videos

Last Updated: Nov 6, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.4K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K

Area of Science:

  • Endocrinology
  • Genetics
  • Psychology

Background:

  • Rare disease research faces challenges due to patient geographic dispersion.
  • Web-based recruitment and patient organization partnerships can overcome these barriers.
  • Critics question the homogeneity and representativeness of online-recruited samples.

Purpose of the Study:

  • To define patient clusters in congenital hypogonadotropic hypogonadism (CHH) using latent class mixture modeling (LCMM).
  • To test the critique that online-recruited patients are a homogenous group with high needs.
  • To demonstrate the validity and transferability of findings from online recruitment methods.

Main Methods:

  • Latent class mixture modeling (LCMM) applied to online-recruited CHH patient data.
  • Included patient demographics, clinical information, Revised Illness Perception Questionnaire (IPQ-R), and Zung Self-Rating Depression Scale (SDS).
  • Analysis aimed to identify distinct patient subgroups based on these characteristics.

Main Results:

  • LCMM identified three distinct patient subgroups (Classes I, II, III) in 154 CHH patients.
  • Subgroups differed significantly in age, education, disease/emotional consequences, illness coherence, depression symptoms, and age at diagnosis.
  • Later diagnosis was significantly associated with worse psychological adaptation and coping.

Conclusions:

  • Three distinct patient classes were identified from online recruitment, refuting prior critiques.
  • Findings support the validity of patient partnership and web-based recruitment for rare disease research.
  • This study provides the first empirical data on negative psychosocial sequelae of a delayed diagnosis in CHH.